红会HONGHUI品牌怎么样 申请店铺

我要投票 红会HONGHUI在医疗器械行业中的票数:554 更新时间:2025-12-12
红会HONGHUI是哪个国家的品牌?「红会HONGHUI」是 桂林红会药业有限公司 旗下著名品牌。该品牌发源于桂林市,由创始人徐 * 国在1992年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力红会HONGHUI品牌出海!将品牌入驻外推网,定制红会HONGHUI品牌推广信息,可以显著提高红会HONGHUI产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

红会HONGHUI怎么样

桂林红会药业有限公司,原名桂林红会制药厂,始创于1992年,是一家大型现代化制药企业。公司于2009年完成改制,并与贵州大学合作成立银杏叶研究院,专业从事银杏叶提取、药品研发,并拥有多项专利技术。

公司位于自古被誉为“楚越往来之要冲”的广西桂林市灵川县,依托当地独特的银杏资源,建立了专业化的集银杏种植、产品转化、生产销售为一体的银杏生态产业园。

公司专注于中、西药成方制剂的研究、生产、销售及开发研制中药新药。目前公司拥有片剂、胶囊剂、颗粒剂、口服液4条生产线,配备有现代化的生产设备和检测仪器,建立了完整的产品质量监控体系。主打产品有心脑血管系列、妇科系列、清热解毒系列、感冒止咳系列、胃肠止痛等6大系近30多种中成药。

公司创立以来,坚持以“专注专业,仁心良药”的企业文化理念,坚持以“专注”的行事准则对制药过程进行严谨的流程控制,建立了完整的产品质量监控体系,严格按GMP进行药品生产与控制,产品具有优良稳定的品质;坚持以“专业”来衡量并不断引进优质的制药技术,不断加大研发投入,配备有高效液相色谱仪、红外分光光度计、原子吸收分光光度计、气相色谱仪等仪器,对原药材、药品进行检测。

红会药业一贯秉承“博爱、奉献”的红会精神,始终具有良心企业强烈的社会责任使命感,在企业壮大的同时,不断地回馈社会。

今天的“红会”更加务实求真,奋力拼搏,红会人正为了“振兴国药,造福人类”贡献自己的智慧和力量。


Guilin Honghui Pharmaceutical Co., Ltd., formerly known as Guilin Honghui pharmaceutical factory, was founded in 1992. It is a large modern pharmaceutical enterprise. The company completed restructuring in 2009, and established ginkgo leaf Research Institute in cooperation with Guizhou University, specializing in Ginkgo leaf extraction, drug research and development, and has a number of patent technologies. The company is located in Lingchuan County, Guilin City, Guangxi Province, which has been known as the "hub of Chu Yue communication" since ancient times. Relying on the unique ginkgo resources, the company has established a professional ginkgo ecological industrial park integrating ginkgo planting, product transformation, production and sales. The company focuses on the research, production, sales and development of new Chinese medicine. At present, the company has 4 production lines of tablet, capsule, granule and oral liquid, equipped with modern production equipment and testing instruments, and established a complete product quality monitoring system. The main products include 6 series of nearly 30 kinds of Chinese patent medicines, such as cardio cerebrovascular series, gynecology series, heat clearing and detoxification series, cold and cough relieving series, gastrointestinal pain relieving series. Since its establishment, the company adheres to the corporate culture concept of "focusing on specialty, caring and good medicine", adheres to the strict process control of the pharmaceutical process based on the principle of "focusing on", establishes a complete product quality monitoring system, strictly carries out drug production and control in accordance with GMP, and the products have excellent and stable quality; Adhere to "professional" to measure and constantly introduce high-quality pharmaceutical technology, constantly increase R & D investment, equipped with high-performance liquid chromatograph, infrared spectrophotometer, atomic absorption spectrophotometer, gas chromatograph and other instruments to test the original medicine and drugs. Honghui pharmaceutical industry has always adhered to the spirit of "fraternity and dedication" and always has a strong sense of social responsibility and mission of conscientious enterprises, and constantly gives back to the society while the enterprises grow. Today's "Red Cross Society" is more pragmatic, realistic and hard-working. People of Red Cross Society are contributing their wisdom and strength to "vitalize national medicine and benefit mankind".

本文链接: https://brand.waitui.com/85c24ea98.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

热门中概股美股盘前多数走弱,拼多多跌超2%

36氪获悉,热门中概股美股盘前多数走弱,截至发稿,拼多多跌超2%,阿里巴巴、B站、理想汽车、小鹏汽车跌超1%,京东跌0.54%;百度涨近1%。

2小时前

汇丰预计美联储明后两年都不会降息

汇丰证券预测,美联储明后两年将维持利率稳定在周三所设定的3.5%-3.75%区间。该机构的美国经济学家Ryan Wang在12月10日的报告中指出,“我们认为,FOMC在整个2026年和2027年将维持联邦基金利率目标区间在3.50%-3.75%不变,但随着经济的演变,和过去一样,需始终关注这一展望面临的重要双向风险。”Wang指出,鲍威尔强调了“2026年经济稳健增长的基本观点,部分得益于财政政策支持及人工智能相关支出”,但同时也存在“劳动力市场逐步降温的证据”。(财联社)

2小时前

良品铺子:“门店动态补货决策数据集”已落地应用,有效缩短采购决策时间

36氪获悉,良品铺子在业绩说明会上表示,公司目前正稳步推进供应链及各项业务的精益管理、降本增效措施,后续将持续加强成本费用管控,推动公司稳健发展。针对区域需求差异下的库存优化,由公司自主研发的“门店动态补货决策数据集”已经落地应用,该系统能有效缩短采购决策时间,优化库存结构。

2小时前

鲸鸿动能斩获艾菲大中华区9项大奖

12月10-11日,在2025大中华区艾菲奖颁奖典礼上,鲸鸿动能斩获艾菲大中华区9项大奖。其中,《〈抚痕倡议〉社会共创运动——为4亿中国妈妈推动改变》获公关奖金奖、场景营销奖铜奖及大健康奖铜奖;《Grab×鲸鸿动能:智慧全场景营销,开启不可思议的旅行》获两项场景营销奖银奖;《同程旅行:实现爆量获客》获效果营销奖铜奖。此外,鲸鸿动能还摘得2025艾菲公关奖最具实效品牌No.1。

2小时前

三季度机构持仓曝光,高毅、淡马锡加仓贝壳

近期,贝壳持续获国际及国内大型金融机构增持。披露显示,国内私募基金巨头高毅资产在今年第三季度增持贝壳约66万股美股,占其持仓约2.15%,为其美股十大重仓股之一。首域盈信在第三季度内增持贝壳约156.6万股美股;淡马锡同期也增持了93万股美股。

2小时前

本页详细列出关于红会HONGHUI的品牌信息,含品牌所属公司介绍,红会HONGHUI所处行业的品牌地位及优势。
咨询